| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8281ac9f4fb11f15a5da018344453338 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0802
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0804 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate |
2008-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f411a0496a93f34f0b80af249c356141
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f6d6cef2439990df626e7b566ed3e1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f65bf29c5aeab185042ca08a74824ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b40147b6917e1be028f6ac2767694e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f89f86c974efb80a31fe530795dcfbc8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e8a3f3873f5921eb9f57df16e0757df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_864f87f1ddd698d887092405ab439c05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92d573083ba72859de14b77d210c438b |
| publicationDate |
2010-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2224920-A1 |
| titleOfInvention |
Process for making macrocyclic oximyl hepatitis c protease inhibitors |
| abstract |
The present invention relates to a process for the preparation of macrocyclic compounds that are useful as hepatitis C virus (HCV) protease inhibitor compounds. |
| priorityDate |
2007-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |